These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 15656623)

  • 1. Mechanism of inactivation of inducible nitric oxide synthase by amidines. Irreversible enzyme inactivation without inactivator modification.
    Zhu Y; Nikolic D; Van Breemen RB; Silverman RB
    J Am Chem Soc; 2005 Jan; 127(3):858-68. PubMed ID: 15656623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic studies of inactivation of inducible nitric oxide synthase by amidines.
    Tang W; Li H; Poulos TL; Silverman RB
    Biochemistry; 2015 Apr; 54(15):2530-8. PubMed ID: 25811913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of acute experimental colitis by a highly selective inducible nitric-oxide synthase inhibitor, N-[3-(aminomethyl)benzyl]acetamidine.
    Kankuri E; Vaali K; Knowles RG; Lähde M; Korpela R; Vapaatalo H; Moilanen E
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1128-32. PubMed ID: 11504810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BYK191023 (2-[2-(4-methoxy-pyridin-2-yl)-ethyl]-3h-imidazo[4,5-b]pyridine) is an NADPH- and time-dependent irreversible inhibitor of inducible nitric-oxide synthase.
    Tiso M; Strub A; Hesslinger C; Kenney CT; Boer R; Stuehr DJ
    Mol Pharmacol; 2008 Apr; 73(4):1244-53. PubMed ID: 18178668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: studies with 1400W, a novel inhibitor.
    Thomsen LL; Scott JM; Topley P; Knowles RG; Keerie AJ; Frend AJ
    Cancer Res; 1997 Aug; 57(15):3300-4. PubMed ID: 9242464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of inducible nitric oxide synthase inactivation by aminoguanidine and L-N6-(1-iminoethyl)lysine.
    Bryk R; Wolff DJ
    Biochemistry; 1998 Apr; 37(14):4844-52. PubMed ID: 9538001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural requirements for human inducible nitric oxide synthase substrates and substrate analogue inhibitors.
    Grant SK; Green BG; Stiffey-Wilusz J; Durette PL; Shah SK; Kozarich JW
    Biochemistry; 1998 Mar; 37(12):4174-80. PubMed ID: 9521739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo.
    Garvey EP; Oplinger JA; Furfine ES; Kiff RJ; Laszlo F; Whittle BJ; Knowles RG
    J Biol Chem; 1997 Feb; 272(8):4959-63. PubMed ID: 9030556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of neuronal nitric oxide synthase inactivation by diverse suicide inhibitors.
    Bryk R; Lubeskie A; Wolff DJ
    Arch Biochem Biophys; 1999 Sep; 369(2):243-51. PubMed ID: 10486143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of an inducible nitric oxide synthase inhibitor on experimentally induced rat pulpitis.
    Kawanishi HN; Kawashima N; Suzuki N; Suda H; Takagi M
    Eur J Oral Sci; 2004 Aug; 112(4):332-7. PubMed ID: 15279652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisense knockdown of inducible nitric oxide synthase inhibits the relaxant effect of VIP in isolated smooth muscle cells of the mouse gastric fundus.
    Dick JM; Van Molle W; Libert C; Lefebvre RA
    Br J Pharmacol; 2001 Sep; 134(2):425-33. PubMed ID: 11564662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of substrate-analogue inhibitors on nitric oxide synthase dimerization.
    Lee KS; Lee DK; Jeoung D; Lee H; Choe J; Ha KS; Won MH; Kwon YG; Kim YM
    Biochem Biophys Res Commun; 2012 Feb; 418(1):49-55. PubMed ID: 22240022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide synthase inhibitors 1400W and L-NIO inhibit angiogenesis pathway of colorectal cancer.
    Gao Y; Zhou S; Xu Y; Sheng S; Qian SY; Huo X
    Nitric Oxide; 2019 Feb; 83():33-39. PubMed ID: 30590117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reperfusion injury is reduced in skeletal muscle by inhibition of inducible nitric oxide synthase.
    Zhang L; Looney CG; Qi WN; Chen LE; Seaber AV; Stamler JS; Urbaniak JR
    J Appl Physiol (1985); 2003 Apr; 94(4):1473-8. PubMed ID: 12506043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic use of selective iNOS inhibitor 1400W or non-selective NOS inhibitor l-NAME differently affects systemic nitric oxide formation after oral Porphyromonas gingivalis inoculation in mice.
    Nemec A; Pavlica Z; Petelin M; Crossley DA; Sentjurc M; Jerin A; Erzen D; Zdovc I; Hitti T; Skaleric U
    Arch Oral Biol; 2010 Jul; 55(7):509-14. PubMed ID: 20430367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of selective and non-selective inhibition of nitric oxide synthase on the expression and activity of cyclooxygenase-2 during gastric ulcer healing.
    Guo JS; Cho CH; Wang JY; Koo MW
    Eur J Pharmacol; 2006 May; 536(3):301-8. PubMed ID: 16600210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of iNOS activity by 1400W decreases glutamate release and ameliorates stroke outcome after experimental ischemia.
    Pérez-Asensio FJ; Hurtado O; Burguete MC; Moro MA; Salom JB; Lizasoain I; Torregrosa G; Leza JC; Alborch E; Castillo J; Knowles RG; Lorenzo P
    Neurobiol Dis; 2005 Mar; 18(2):375-84. PubMed ID: 15686966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actions of isoform-selective and non-selective nitric oxide synthase inhibitors on endotoxin-induced vascular leakage in rat colon.
    László F; Whittle BJ
    Eur J Pharmacol; 1997 Sep; 334(1):99-102. PubMed ID: 9346334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of nitric oxide donor S-nitroso-N-acetylcysteine to selective iNOS inhibitor 1400W further improves contractile function in reperfused skeletal muscle.
    Barker JU; Qi WN; Cai Y; Urbaniak JR; Chen LE
    Microsurgery; 2005; 25(4):338-45. PubMed ID: 15880470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of iNOS with 1400W improves contractile function and alters nos gene and protein expression in reperfused skeletal muscle.
    Patel P; Qi WN; Allen DM; Chen LE; Seaber AV; Stamler JS; Urbaniak JR
    Microsurgery; 2004; 24(4):324-31. PubMed ID: 15274192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.